
Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
latest_posts
- 1
Transcript: NASA's Jared Isaacman on "Face the Nation with Margaret Brennan," April 5, 2026 - 2
Famous Restroom Beautifying Styles For 2024 - 3
Heartfelt Objections to Visit with Your Adored One - 4
Burger King launches 'SpongeBob' menu ahead of film's release. A look at the Bikini Bottom-inspired meal, plus what taste testers are saying. - 5
Novo Nordisk cuts Wegovy price as CEO pledges to go 'all in' on weight loss pill
The most exciting exoplanet discoveries of 2025
Elanco's drug gets emergency nod to treat deadly flesh-eating parasite in cats
As tetanus vaccination rates decline, doctors worry about rising case numbers
Nikki Glaser has been testing out Golden Globes jokes. There's one nobody wants to hear
Israel and Lebanon's Hezbollah continue to trade attacks
Latvia seeks emergency UN meeting over Russian missile attack on Lviv
Find the Insider facts of Viable Advertising: Building a Positive Brand Picture
Figure out How to Amplify the Resale Worth of Your Kona SUV
Watch SpaceX launch NASA's Pandora exoplanet-studying satellite on Jan. 11












